Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification
DOI: https://doi.org/10.2147/ijgm.s459953
IF: 2.145
2024-05-17
International Journal of General Medicine
Abstract:Yue Shao, Rong Li, Guangmei Chen, Lichuan Zhang Department of Respiratory Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China Correspondence: Lichuan Zhang, Department of Respiratory Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China, Email Purpose: We explored the expression and prognostic value of GALNT6 and the tumor microenvironment of pan-cancer in humans. Methods: In this study, we explored the expression pattern of GALNT6 pan-cancer across multiple databases. The prognostic value of GALNT6 was evaluated using the Kaplan–Meier method. The types and numbers of GALNT6 gene alterations were exhibited using the cBio Cancer Genomics Portal. The correlations between GALNT6 expression and immune infiltration in cancers were analyzed using the database Tumor Immune Estimation Resource 2. We also used the Kyoto Encyclopedia of Genes and Genomes pathway and Gene Ontology analysis to investigate the molecular mechanisms of the GALNT6 gene in tumorigenesis. The expression of GALNT6 was also further verified by qPCR in lung adenocarcinoma tissues. Results: In general, compared with normal tissue, tumor tissue had a higher expression level of GALNT6. GALNT6 showed a protective effect in colon carcinoma and other cancers; however, a high expression level of GALNT6 was detrimental to survival in bladder cancer and in pheochromocytoma and paraganglioma. Mutation, amplification, and deep deletion were the three main types of GALNT6 mutations in tumors. There was a significant positive correlation between GALNT6 expression and immune infiltration of CD8+ T-cells in skin cutaneous melanoma metastasis, based on most of the algorithms used. Moreover, protein processing- and glycoprotein metabolic-associated functions were involved in the functional mechanisms of GALNT6. Conclusion: This first pan-cancer study offers a relatively comprehensive understanding of the oncogenic roles of GALNT6 across different cancer types. Keywords: GALNT6, pan-cancer, survival analysis, mutation, immune infiltration, functional mechanisms Cancer is a major public health problem worldwide 1,2 and the dominant cause of premature death and decreased life expectancy in many countries. 3 The hallmarks of cancer were proposed as a set of functional capabilities acquired by human cells as they make their way from normalcy to forming malignant tumors. The hallmarks currently comprise sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing and accessing vasculature, activating invasion and metastasis, reprogramming cellular metabolism, and avoiding immune destruction. 4 Given the complexity of cancer phenotypes and genotypes, it is important to conduct a pan-cancer expression analysis of genes of interest and assess their correlation with clinical prognosis and potential molecular mechanisms. Polypeptide N-acetylgalactosaminyltransferase 6 (GALNT6), also known as GALNAC-T6 or GalNAcT6, is located on chromosome 12q13, and was first identified as an enzyme in the initiation of O-glycosylation. 5 Glycosylation is a dynamic process of glycoconjugate synthesis that can modulate inflammatory responses, enable viral immune escape, and regulate apoptosis or promote cancer cell metastasis. 6 Mucin-type O-linked protein glycosylation can be initiated by GALNT family members that transfer GalNAc to serine or threonine residues on the target protein. 7 This modification occurs in the Golgi complex. 8 Biochemical and biological function analyses of GALNT6 have been conducted from the perspective of physiology across different species. 9–11 Previous studies have explored the effects of GALNT6 in tumors, suggesting that GALNT6 is of great importance in cancer development. The role of GALNT6 in tumors was first reported for breast cancers, and overexpression of GALNT6 may contribute to mammary carcinogenesis through aberrant glycosylation and stabilization of MUC1. 12 Overexpression of GALNT6 in serous ovarian carcinomas was found using the independently derived Affymetrix GeneChip Human Genome U133 Plus 2.0 array. Moreover, GALNT6 expression was correlated with a higher risk of disease progression and poor prognosis in serous epithelial ovarian cancer patients. 13 Further studies are needed to more completely elucidate, in vitro and in vivo, the role of the GALNT6 gene in ovarian tumorigenesis. A previous study analyzed the molecular differences between B-cell precursor acute lymphoblastic leukemia and T-lineage acute lymphoblastic leukemia and identified the multi-omics signatures using Boruta and Monte -Abstract Truncated-
medicine, general & internal